Does TOFACITINIB Cause Therapeutic product effect incomplete? 4,914 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 4,914 reports of Therapeutic product effect incomplete have been filed in association with TOFACITINIB (XELJANZ XR). This represents 3.2% of all adverse event reports for TOFACITINIB.
4,914
Reports of Therapeutic product effect incomplete with TOFACITINIB
3.2%
of all TOFACITINIB reports
511
Deaths
925
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From TOFACITINIB?
Of the 4,914 reports, 511 (10.4%) resulted in death, 925 (18.8%) required hospitalization, and 420 (8.5%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 4,914 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
INFLIXIMAB (3,372)
Which TOFACITINIB Alternatives Have Lower Therapeutic product effect incomplete Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN